Phosphatidylinositol 3-kinase is required for growth factor-induced amino acid uptake by vascular smooth muscle cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 9, 1999, Pages 2127-2132

  Higaki, Masahide ^a,b   Shimokado, Kentaro ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

Amino acid uptake; Phosphatidylinositol 3 kinase; Platelet derived growth factor; Transforming growth factor

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; AMINO ACID; ANGIOTENSIN; ARGININE; GROWTH FACTOR; LEUCINE; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROLINE; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; VASOACTIVE AGENT; WORTMANNIN;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVITY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

EID: 0032868499     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.9.2127     Document Type: Article

References (31)

1. Christensen HN. Role of amino acid transport and countertransport in nutrition and metabolism. Physiol Rev. 1990;70:43-77.
2. Malandro MS, Kilberg MS. Molecular biology of mammalian amino acid transporters. Annu Rev Biochem. 1996;65:305-336.
3. Obata T, Kashiwagi A, Maegawa H, Nishio Y, Ugi S, Hidaka H, Kikkawa R. Insulin signaling and its regulation of system A amino acid uptake in cultured rat vascular smooth muscle cells. Circ Res. 1996;79:1167-1176.
4. Low BC, Ross IK, Grigor MR. Glucose deprivation and acute cycloheximide treatment stimulate system L amino acid transport in cultured vascular smooth muscle cells. J Biol Chem. 1994;269:32098-32103.
5. Durante W, Liao L, Iftikhar I, Cheng K, Schafer AI. Platelet-derived growth factor regulates vascular smooth muscle cell proliferation by inducing cationic amino acid transporter gene expression. J Biol Chem. 1996;271:11838-11843.
6. Duclos MJ, Chevalier B, Goddard C, Simon J. Regulation of amino acid transport and protein metabolism in myotubes derived from chicken muscle satellite cells by insulin-like growth factor-I. J Cell Physiol. 1993;157:650-657.
7. Boerner P, Resnick RJ, Racker E. Stimulation of glycolysis and amino acid uptake in NRK-49F cells by transforming growth factor β and epidermal growth factor. Proc Natl Acad Sci U S A. 1985;82:1350-1353.
8. Low BC, Grigor MR. Angiotensin II simulates system y+ and cationic amino acid transporter gene expression in cultured vascular smooth muscle cells. J Biol Chem. 1995;270:27577-27583.
9. Le Marchand-Brustel Y, Gautier N, Cormont M, Van Obberghen E. Wortmannin inhibits the action of insulin but not that of okadaic acid in skeletal muscle: comparison with fat cells. Endocrinology. 1995;136: 3564-3570.
10. Sanchez-Margalet V, Goldfine ID, Vlahos CJ, Sung CK. Role of phosphatidylinositol 3-kinase in insulin receptor signaling: studies with inhibitor, LY294002. Biochem Biophys Res Commun. 1994;204:446-452.
11. Su TZ, Wang M, Syu LJ, Saltiel AR, Oxender DL. Regulation of system A amino acid transport in 3T3-L1 adipocytes by insulin. J Biol Chem. 1998;273:3173-3179.
12. Higaki M, Sakaue H, Ogawa W, Kasuga M, Shimokado K. Phosphatidylinositol 3-kinase-independent signal transduction pathway for platelet-derived growth factor-induced chemotaxis. J Biol Chem. 1996;271: 29342-29346.
13. Shimokado K, Yokota T, Umezawa K, Sasaguri T, Ogata J. Protein tyrosine kinase inhibitors inhibit chemotaxis of vascular smooth muscle cells. Arterioscler Thromb. 1994;14:973-981.
14. Gronwald RG, Grant FJ, Haldeman BA, Hart CE, O'Hara PJ, Hagen FS, Ross R, Bowen-Pope DF, Murray MJ. Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class. Proc Natl Acad Sci U S A. 1988;85: 3435-3439.
15. Hara K, Yonezawa K, Sakaue H, Ando A, Kotani K, Kitamura T, Kitamura Y, Ueda H, Stephens L, Jackson TR, Hawkins PT, Dhand R, Clark AE, Holman GD, Waterfield MD, Kasuga M. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc Natl Acad Sci U S A. 1994;91:7415-7419.
16. Owen AJ 3d, Geyer RP, Antoniades HN. Human platelet-derived growth factor stimulates amino acid transport and protein synthesis by human diploid fibroblasts in plasma-free media. Proc Natl Acad Sci U S A. 1982;79:3203-3207.
17. Moran A, Brown DM, Kim Y, Klein DJ. Effect of IGF-I and glucose on protein and proteoglycan synthesis by human fetal mesangial cells in culture. Diabetes. 1991;40:1346-1354.
18. Weerackody RP, Chatterjee PK, Mistry SK, McLaren J, Hawksworth GM, McLay JS. Selective antagonism of the AT1 receptor inhibits the effect of angiotensin II on DNA and protein synthesis of rat proximal tubular cells. Exp Nephrol. 1997;5:253-262.
19. Franke TF, Kaplan DR, Cantley LC. PI3K: downstream AKTion blocks apoptosis. Cell. 1997;88:435-437.
20. Low BC, Ross IK, Grigor MR. Characterization of system L and system y+ amino acid transport activity in cultured vascular smooth muscle cells. J Cell Physiol. 1993;156:626-634.
21. McDonald KK, Zharikov S, Block ER, Kilberg MS. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the 'arginine paradox.' J Biol Chem. 1997;272: 31213-31216.
22. Kikuta K, Sawamura T, Miwa S, Hashimoto N, Masaki T. High-affinity arginine transport of bovine aortic endothelial cells is impaired by lysophosphatidylcholine. Circ Res. 1998;83:1088-1096.
23. Heldin CH. Protein tyrosine kinase receptors. Cancer Surv. 1996; 27:7-24.
24. Massague J. TGF-β signaling: receptors, transducers, and Mad proteins. Cell. 1996;85:947-950.
25. Powis G, Bonjouklian R, Berggren MM, Gallegos A, Abraham R, Ashendel C, Zalkow L, Matter WF, Dodge J, Grindey G, Vlahos CJ. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res. 1994;54:2419-2423.
26. Vlahos CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem. 1994;269:5241-5248.
27. Yano H, Agatsuma T, Nakanishi S, Saitoh Y, Fukui Y, Nonomura Y, Matsuda Y. Biochemical and pharmacological studies with KT7692 and LY294002 on the role of phosphatidylinositol 3-kinase in Fc εRI-mediated signal transduction. Biochem J. 1995;312:145-150.
28. Saad MJ, Velloso LA, Carvalho CR. Angiotensin II induces tyrosine phosphorylation of insulin receptor substrate 1 and its association with phosphatidylinositol 3-kinase in rat heart. Biochem J. 1995;310:741-744.
29. Velloso LA, Folli F, Sun XJ, White MF, Saad MJ, Kahn CR. Cross-talk between the insulin and angiotensin signaling systems. Proc Natl Acad Sci U S A. 1996;93:12490-12495.
30. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, Marumo F, Inagami T. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem. 1998;273:8890-8896.
31. Domin J, Dhand R, Waterfield MD. Binding to the platelet-derived growth factor receptor transiently activates the p85α-p110α phosphatidylinositide 3-kinase complex in vivo. J Biol Chem. 1996;271:21614-21621.